Open-source autonomous in silico drug-discovery pipeline for Korean traditional medicine: Boltz-2 + OpenFold3 + AQAffinity + REINVENT4 + OpenMM ABFE + cost-aware multi-fidelity BO scheduler. 19 bioRxiv preprints. Recover Korean Medicine Clinic (Seoul, opening planned for late August 2026) translational anchor.
ai openmm drug-discovery biorxiv dermatology bayesian-optimization natural-products in-silico multi-fidelity admet abfe korean-medicine boltz-2 openfold3 aqaffinity reinvent4
-
Updated
Aug 8, 2026 - HTML